News for Sanofi (SNY)

As of March 11, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading...

**media[560956]**

**media[560955]**

**media[549237]**

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other pharmaceutical...

Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that provide patient care, research and development of new medicines...

Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ETNew detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitu

**media[547081]**

**media[547076]**

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

Sanofi to sell a 50% stake in Opella, its consumer healthcare unit, to CD&R.

**media[543950]**

**media[542808]**

Sanofi (SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog. Read more here.

**media[540288]**

We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other international dividend...

Dividend stocks have been grabbing investors' attention for a while now.

Sanofi (SNY) launches €5 billion stock buyback program, successfully executing first tranche with €3 billion off-market block trade with L'Oréal.

**media[534704]**